Status:

UNKNOWN

HFAC Stimulation (30-50 Kilohertz) in Healthy Volunteers (High Frequency Alternating Current Stimulation)

Lead Sponsor:

University of Castilla-La Mancha

Collaborating Sponsors:

Ministry of Science and Innovation, Spain

Conditions:

Healthy

Nerve Block

Eligibility:

All Genders

18-40 years

Phase:

NA

Brief Summary

High-frequency alternating current (HFAC) stimulation (between 1 kilohertz (kHz) and 100 kHz) on the peripheral nerve has been shown in basic animal research to produce a rapidly reversible nerve bloc...

Detailed Description

Electrical stimulation with high-frequency alternating currents (between 1 kHz and 100 kHz) on the peripheral nerve has shown, in basic research with animals, that it produces a rapidly reversible ner...

Eligibility Criteria

Inclusion

  • Healthy volunteer participants.
  • Ability to perform all clinical tests and understand the study protocol, as well as obtain informed consent.
  • Tolerance to the application of electrotherapy.

Exclusion

  • Having been treated with an electric current similar to the one applied prior to the intervention.
  • Neurological pathology of peripheral or central origin.
  • Altered sensitivity in the area of application of the intervention.
  • No compromise of continuity.
  • History of neuromuscular disease.
  • Epilepsy.
  • Trauma, surgery or pain affecting the upper limb.
  • Diabetes.
  • History of cancer.
  • Cardiovascular, metabolic or immunological diseases.
  • Presence of pacemaker or any other implanted electrical device.
  • Taking medication during the study and in the 7 days prior to the study.
  • Consumption of narcotic substances during the study and in the 7 days prior to the study.
  • Presence of tattoos or any other external agent introduced in the area of treatment and treatment and assessment area (hand).
  • Pregnancy.

Key Trial Info

Start Date :

February 10 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 25 2022

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT05230836

Start Date

February 10 2022

End Date

December 25 2022

Last Update

May 16 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Castilla-La Mancha University

Toledo, Spain, 45071